These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 4764833)

  • 1. [Current bronchodilating substances].
    Magazanik NA
    Klin Med (Mosk); 1973 Jan; 51(1):135-9. PubMed ID: 4764833
    [No Abstract]   [Full Text] [Related]  

  • 2. [How does the patient use his bronchodilating dose-aerosol?].
    Arvastson B; Björkander J; Eklundh G; Korsgaard R; Pelkin S; Riebe I; Simonsson BG; Stiksa G; Werner S
    Lakartidningen; 1976 Apr; 73(15):1407-9. PubMed ID: 1263658
    [No Abstract]   [Full Text] [Related]  

  • 3. [Bronchial obstruction in complicated pulmonary hydatid disease: methods of its correction at the stage of preoperative preparation].
    Ismailov DA; Sharafutdinova GKh; Pakhomov GL; Ugarova TB; Akmeev VR
    Probl Tuberk Bolezn Legk; 2006; (9):51-4. PubMed ID: 17128803
    [No Abstract]   [Full Text] [Related]  

  • 4. [Mechanism of action and indications for administration of some bronchodilator agents].
    Nikodýmová L; Růzicka J
    Cas Lek Cesk; 1971 Oct; 110(41):945-50. PubMed ID: 5112128
    [No Abstract]   [Full Text] [Related]  

  • 5. [Standardization and description of spirometric technics in evaluation of effects of bronchodilator drugs].
    Minette A
    Acta Tuberc Pneumol Belg; 1968; 59(4):529-40. PubMed ID: 5739743
    [No Abstract]   [Full Text] [Related]  

  • 6. [Misuse of pressurized metered-dose aerosols in the treatment of bronchial diseases. Incidence and clinical consequences].
    Chinet T; Huchon G
    Ann Med Interne (Paris); 1994; 145(2):119-24. PubMed ID: 8024176
    [No Abstract]   [Full Text] [Related]  

  • 7. [Test of activity of bronchodilatory effective substances with whole body plethysmography].
    Uhl O
    Acta Tuberc Pneumol Belg; 1968; 59(4):710-23. PubMed ID: 5739758
    [No Abstract]   [Full Text] [Related]  

  • 8. [Results obtained with bronchodilator aerosol of 1-(3,5 dehydroxyphenyl)-2-isopropylaminoethanol sulphate].
    Ruiz Benítez G
    Rev Clin Esp; 1966 Aug; 102(4):305-10. PubMed ID: 5995634
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical use of decloxizine].
    Serembe M; Pivirotto F; Cipriani A
    Acta Tuberc Pneumol Belg; 1968; 59(4):562-70. PubMed ID: 4904305
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical study of bronchodilator effects of decloxizine by intravenous route and, in increasing doses, by peroral route].
    Minette A; Bruninx M
    Acta Tuberc Pneumol Belg; 1968; 59(4):571-82. PubMed ID: 4904306
    [No Abstract]   [Full Text] [Related]  

  • 11. [The role of mucolysis in the treatment of respiratory diseases].
    Müller M
    Orv Hetil; 1971 Oct; 112(43):2593-4. PubMed ID: 5133203
    [No Abstract]   [Full Text] [Related]  

  • 12. Double-blind comparative trial of two metered bronchodilator aerosols.
    Gent PN; Hughes DT; Nisbet IG; Pearson SB; Sturgeon JG
    Br J Clin Pract; 1968 Nov; 22(11):479-81. PubMed ID: 4880250
    [No Abstract]   [Full Text] [Related]  

  • 13. [Broncholytic agents].
    Belashkin II
    Feldsher Akush; 1987 Mar; 52(3):47-51. PubMed ID: 3647884
    [No Abstract]   [Full Text] [Related]  

  • 14. [The influence of orciprenaline on the regional relationships between ventilation and perfusion in irreversible bronchial obstruction].
    Stiksa J; Daum S; Nikodýmová L
    Arzneimittelforschung; 1967 May; 17(5):568-72. PubMed ID: 5631586
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of bronchial obstruction with beta-2-mimetic and anticholinergic agents in aerosol. Advantages of the combination of both groups of pharmaceuticals].
    Minette A; Marcq M
    Rev Inst Hyg Mines (Hasselt); 1980; 35(2):85-114. PubMed ID: 6111836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Study of the possible effect of decloxizine on blood gas levels].
    Vaerenberg C
    Acta Tuberc Pneumol Belg; 1968; 59(4):633-6. PubMed ID: 5739751
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical testing of a bronchospasmolytic drug in retard form].
    Aleksic SI
    Med Welt; 1975 Sep; 26(38):1733-7. PubMed ID: 1102834
    [No Abstract]   [Full Text] [Related]  

  • 18. Preliminary titration of the airway effects of a new bronchodilator aerosol (soterenol, MJ 1992) in humans with obstructive ventilatory disorders.
    Cohen BM
    Curr Ther Res Clin Exp; 1969 Dec; 11(12):713-26. PubMed ID: 4984035
    [No Abstract]   [Full Text] [Related]  

  • 19. [Advantage of a new therapeutic agent for respiratory dyspneic diseases].
    Blamoutier J; Mot JC; Travagli JP
    Therapeutique; 1970 Oct; 46(8):793-5. PubMed ID: 5458911
    [No Abstract]   [Full Text] [Related]  

  • 20. Bronchospasmolytics. Introduction.
    Meyer H
    Respiration; 1969; 26():Suppl:91-4. PubMed ID: 5381387
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.